NCT05013229 · Interventional trial
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)
Overall registry status Completed
Phase 3
Conditions Diabetes Mellitus, Type 2
Delaware Valley sites
- John J Shelmet, MD · Lawrenceville, NJ · Mercer County
First posted
Registry updated
Added to the directory